All >

News > Germany

Total search results: 5871 | Ordered by Date (descending)
1 2 3 ... 57 58 59  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. 2019-08-20
Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. 2019-08-20
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. 2019-08-12
Nynomic AG. (8/12/19). "Press Release: Acquisition of the Business Operations of LemnaTec GmbH Strengthens Technological Competence in the Field of Plant Phenotyping". Wedel. 2019-08-12
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. 2019-08-08
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. 2019-08-06
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE. 2019-08-06
Imcyse. (8/5/19). "Press Release: Imcyse Announces Changes in Management and Board, Appoints Thomas Taapken as Executive Chairman". Liège. 2019-08-05
Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin. 2019-08-05
GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. 2019-08-05
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". 2019-08-02
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". 2019-07-31
Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. 2019-07-31
Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. 2019-07-31
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Evotec SE. (7/25/19). "Press Release: P2X3 Antagonist Demonstrates Efficacy against Refractory Chronic Cough in Phase II (POC)". Hamburg. 2019-07-25
Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. 2019-07-23
Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. 2019-07-22
Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt. 2019-07-18
Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. 2019-07-18
Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. 2019-07-18
Evogene Ltd.. (7/16/19). "Press Release: Evogene Amends Its Collaboration Agreement with Bayer to Include Genome Editing Targets". Rehovot. 2019-07-16
Evotec SE. (7/15/19). "Press Release: Evotec Expands Its iPSC Platform. Acquired Assets from Ncardia AG". Hamburg. 2019-07-15
Inscreenex GmbH. (7/15/19). "Press Release: Inscreenex Wins Horizon 2020 SME Instrument Phase-1 Support". Braunschweig. 2019-07-15
Boehringer Ingelheim. (7/15/19). "Press Release: Boehringer Ingelheim Acquires Amal Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform". Ingelheim & Geneva. 2019-07-15
Vasopharm GmbH. (7/11/19). "Press Release: Vasopharm Closes € 9.5 Million Financing Round". 2019-07-11
Berlin Institute of Health. (7/10/19). "Press Release: A New Chapter for the Berlin Institute of Health". 2019-07-10
Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. 2019-07-10
AiCuris Anti-infective Cures GmbH. (7/9/19). "Press Release: AiCuris and Lysando Join Forces in the Fight against Antimicrobial Resistance". Wuppertal & Balzers. 2019-07-09
Cytosurge AG. (7/9/19). "Press Release: Olympus Europe and Cytosurge Partner to Enhance Pharma Drug Development and Single Cell Research". Zurich / Glattbrugg & Hamburg. 2019-07-09
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. 2019-07-09
MorphoSys AG. (7/8/19). "Press Release: MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology". Planegg & Halle (Saale). 2019-07-08
Immatics Biotechnologies GmbH. (7/8/19). "Press Release: Immatics Appoints Harpreet Singh as Chief Executive Officer". Tübingen & Houston, TX. 2019-07-08
Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". 2019-07-08
Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. 2019-07-08
Evotec SE. (7/8/19). "Press Release: Evotec and Venture Capital Consortium Form Breakpoint Therapeutics GmbH". Hamburg. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
SMS-Oncology (Specialized Medical Services-Oncology B.V.). (7/8/19). "Press Release: SMS-Oncology Opens New Office in Frankfurt, Germany". Schiphol. 2019-07-08
GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. 2019-07-03
Evotec SE. (7/3/19). "Press Release: Evotec Completes Acquisition of Just Biotherapeutics". Hamburg. 2019-07-03
Confo Therapeutics N.V.. (7/3/19). "Press Release: Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-modulating Compounds". Ghent & Dresden. 2019-07-03
High-Tech Gründerfonds Management GmbH. (7/3/19). "Press Release: “First-in-Class“ mRNA-therapeutics for Vascular Diseases – Pantherna Therapeutics Receives 7-digit Investment". 2019-07-03
Nosopharm S.A.S.. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. 2019-07-03
MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg. 2019-07-03
Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. 2019-07-02
Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. 2019-07-02
Boehringer Ingelheim. (7/1/19). "Press Release: Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline with New First-in-Class Compound from Yuhan Corporation". Ingelheim & Seoul. 2019-07-01
R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt. 2019-07-01
Merck KGaA. (7/1/19). "Press Release: Merck Places Bonds Amounting to € 2 Billion. Issuance Is Final Key Component in the Financing of the Planned Versum Transaction". Darmstadt. 2019-07-01
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
Curetis N.V.. (6/28/19). "Press Release: Curetis Reports Results of the Annual General Meeting Held on June 27, 2019. All Proposed AGM Resolutions Approved by Shareholders". Amsterdam, San Diego, CA & Holzgerlingen. 2019-06-28
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
Modag GmbH. (6/27/19). "Press Release: Modag Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy". Wendelsheim. 2019-06-27
Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg. 2019-06-27
Evotec SE. (6/26/19). "Press Release: Evotec SE Places First Schuldschein (Promissory Note) Worth EUR 250 m". Hamburg. 2019-06-26
Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. 2019-06-25
MorphoSys AG. (6/24/19). "Press Release: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer". Planegg. 2019-06-24
Merck KGaA. (6/18/19). "Press Release: Merck Places Hybrid Bond Amounting to € 1.5 Billion. Placement Is an Important Part of the Financing of the Planned Acquisition of Versum Materials, Inc.". Darmstadt. 2019-06-18
German Accelerator Life Sciences. (6/18/19). "Press Release: German Accelerator Appoints Marc Filerman as CEO Life Sciences". Munich & Cambridge, MA. 2019-06-18
Probiodrug AG. (6/12/19). "Press Release: Probiodrug AG Becomes Vivoryon Therapeutics AG". Halle (Saale). 2019-06-12
MaRS Innovation. (6/11/19). "Press Release: LAB150 Adds Project with Focus on Mental Health". Toronto, ON. 2019-06-11
Boehringer Ingelheim. (6/11/19). "Press Release: The Healthcare of Tomorrow – Boehringer Ingelheim Relies on Digital Transformation". Ingelheim. 2019-06-11
Merck & Co., Inc.. (6/10/19). "Press Release: Merck to Acquire Tilos Therapeutics". Kenilworth, NJ. 2019-06-10
Evotec SE. (6/10/19). "Press Release: Evotec Receives $23.8m Grant to Join the Global Fight against Tuberculosis". Hamburg. 2019-06-10
Merck KGaA. (6/6/19). "Press Release: Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology". Darmstadt. 2019-06-06
Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia. 2019-06-05
Evotec SE. (6/5/19). "Press Release: Evotec and Celgene further Expand iPSC Collaboration including New Cell Type". Hamburg. 2019-06-05
InflaRx N.V.. (6/5/19). "Press Release: InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa". Jena. 2019-06-05
Schott AG. (6/5/19). "Press Release: Schott AG to Acquire Australian Microfluidic Expert MiniFAB". Melbourne & Mainz. 2019-06-05
Spindiag GmbH. (6/4/19). "Press Release: Spindiag’s Continued Road to Success. Expansion of Series A with an additional 4 Million Euros for Market Entry". Freiburg. 2019-06-04
Bruker Corporation. (5/31/19). "Press Release: Bruker Launches timsTOF fleX with ESI and MALDI for SpatialOMx". Atlanta, GA. 2019-05-31
[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme 2019-05-30
Foundation Medicine, Inc.. (5/29/19). "Press Release: Bayer and Foundation Medicine Announce Global Collaboration To Develop Next-generation Sequencing (NGS)-based Companion Diagnostics In Oncology". Cambridge, MA & Berlin. 2019-05-29
Vibalogics GmbH. (5/29/19). "Press Release: Ampersand Capital Partners to Acquire Vibalogics GmbH". Cuxhaven & Wellesley, MA. 2019-05-29
BRAIN AG. (5/29/19). "Press Release: BRAIN AG Achieves Significant Growth in the First Half of the 2018/19 Financial Year". Zwingenberg. 2019-05-29
Centogene AG. (5/28/19). "Press Release: Centogene iPSC Technology Solutions to Support Disease Modeling. Accelerated Orphan Drug Development". Rostock & Cambridge, MA. 2019-05-28
Affimed N.V.. (5/22/19). "Press Release: Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio, Reports First Quarter 2019 Financial Results and Operational Progress". Heidelberg. 2019-05-22
Labfolder GmbH. (5/22/19). "Press Release: Lab Notebook Learns to Communicate with Laboratory Devices. Labfolder Acquires Cubuslab and Becomes Labforward". Berlin & Karlsruhe. 2019-05-22
Evotec SE. (5/20/19). "Press Release: Evotec Jump-starts Biologics with Acquisition of Just Biotherapeutics". Hamburg. 2019-05-20
Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. 2019-05-20
MorphoSys AG. (5/16/19). "Press Release: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, Has Been MMet, Confirming Previously Published Activity". Planegg. 2019-05-16
Roche. (5/16/19). "Press Release: Roche Announces FDA Approval for Venclexta plus Gazyva for People with Previously Untreated Chronic Lymphocytic Leukaemia". Basel. 2019-05-16
Werum IT Solutions AG. (5/16/19). "Press Release: Jens Woehlbier Assigned as New CEO of Werum IT Solutions". Lüneburg. 2019-05-16
Qiagen N.V.. (5/16/19). "Press Release: Qiagen and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions". Hilden, Germantown, MD & Plymouth Meeting, PA. 2019-05-16
High-Tech Gründerfonds Management GmbH. (5/15/19). "Press Release: Navan Closes Seed Funding Round – Investors include Amgen Ventures, HTGF and Hemi Ventures". 2019-05-15
Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg. 2019-05-15
ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. 2019-05-15
Evotec SE. (5/14/19). "Press Release: Evotec SE Reports First Quarter 2019 Results and Provides Corporate Update". Hamburg. 2019-05-14
F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge. 2019-05-14
SensID GmbH. (5/14/19). "Press Release: SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards". Göteborg & Rostock. 2019-05-14
Medigene AG. (5/14/19). "Press Release: Medigene Reports Financial & Business Results for the First Three Months of 2019". Martinsried. 2019-05-14
Centogene AG. (5/13/19). "Press Release: Centogene Launches Two Year Global Parkinson's Disease Study". Cambridge, MA & Rostock. 2019-05-13
Qiagen N.V.. (5/10/19). "Press Release: Disclosure According to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase". 2019-05-10
Roche Diagnostics GmbH. (5/10/19). "Pressemitteilung: Neuer Geschäftsführer Personal bei der Roche Diagnostics GmbH. Mit Wirkung zum 1. Juni 2019 folgt Andreas Schmitz auf Edgar Vieth". Mannheim & Penzberg. 2019-05-10
Medigene AG. (5/9/19). "Press Release: Bluebird Presents Preclinical Data of First TCR Candidate from Medigene Collaboration. Start Clinical Development 2020". Martinsried. 2019-05-09
Centogene AG. (5/9/19). "Press Release: Centogene Expands Executive Leadership Team". Cambridge, MA & Rostock. 2019-05-09
1 2 3 ... 57 58 59  next pagenext page



Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x113px

» top